Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold
Authors:
- Giulia BononiGBGiulia Bononi
- Francesca GadoFGFrancesca Gado
- Samuele MasoniSMSamuele Masoni
- Diana ScalabriniDSDiana Scalabrini
- Larissa Della VedovaLVLarissa Della Vedova
- Miriana Di StefanoMSMiriana Di Stefano
- Lisa PiazzaLPLisa Piazza
- Clarissa PolesCPClarissa Poles
- Chiara LonziCLChiara Lonzi
- Eva LanducciELEva Landucci
- Chiara VagagginiCVChiara Vagaggini
- Federica PoggialiniFPFederica Poggialini
- 19 June 2025
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 163
Abstract
No abstract availableKeywords
Funding Information
- University of Saskatchewan
This publication has 49 references indexed in Scilit:
- NRF2 modulation in TRAMP mice: an in vivo model of prostate cancerMolecular Biology Reports, 2022
- Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and SchizophreniaMolecular Neurobiology, 2022
- Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid‐induced osteonecrosis of the femoral headClinical and Translational Medicine, 2021
- Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disordersActa Pharmaceutica Sinica B, 2020
- A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple SclerosisAngewandte Chemie International Edition, 2014
- The P harmacologic and C linical E ffects of M edical C annabisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionProtein Science, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptorNeuropharmacology, 1990